CRL - Charles River Laboratories International Inc
This page shows which of the focused investors we track hold CRL and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2022 it was held by 3 managers with an aggregate reported value of $252.46M, which is 0.03% of the combined portfolio.
As of Q4 2022, 3 tracked institutional managers held CRL (Charles River Laboratories International Inc) with an aggregate reported value of $252.46M — 0.03% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades CRL — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2022
- Ticker
- CRL
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Ariel Investments - Ariel Investments | 1.41% | Reduce -2.0% | 637,762 | $138.97M |
| 2 | Viking Global Investors - Viking Global Investors | 0.56% | Reduce -21.8% | 515,168 | $112.26M |
| 3 | Polen Capital Management - Polen Capital Management | 0.00% | Add +22.3% | 5,688 | $1.24M |
Loading holder history for CRL…